Altasciences Expands Strategic Support in Europe and Adds Key Employees to Its Preclinical Team
Altasciences hired two expert advisors to support its strategic growth in Europe, while its preclinical team continues to expand with the addition of two key employees.
Providing strategic input into steering Altasciences’ drug development solutions direction in Europe, Peter Varney joins the company as Pharma Development and Strategy Advisor. Peter brings 40 years of experience in commercial development, strategic alliances, and relationship management at Covance to his new position. Hazel Clay, with over 30 years of experience in supporting the development of innovator pharmaceutical assets at Covance, plays a key role as Drug Development Advisor in Altasciences’ European expansion. Both Peter and Hazel are based out of Altasciences’ offices in Harrogate, UK.
“With their extensive experience and keen strategic vision, Peter and Hazel are important assets to Altasciences’ expansion into the European market. We wanted to provide our European clients access to in-depth knowledge on early phase drug development to help them get better drugs to market faster,” stated Chris Perkin, Altasciences’ Chief Executive Officer.
In addition, Dr. Lisa Biegel joins Altasciences as Senior Scientific Director, Preclinical Services, and will be based at the Columbia, MO, facility. With over 30 years of industry experience in regulatory toxicology at Covance, Lisa will provide leadership and oversight, as well as strategic scientific input, to the study direction and reporting teams.
Furthermore, Annette Kenser joins Altasciences as Senior Director of Quality Assurance, Preclinical Research. Annette has extensive experience as a scientific quality assurance auditor, and will focus on identifying areas of improvement while aligning quality assurance activities throughout the organization.
“We are pleased to welcome Lisa and Annette to Altasciences, and look forward to benefitting from their talents and contributions in the preclinical space,” said Andy Brown, Site Director at Altasciences’ Columbia preclinical facility.
About Altasciences
Altasciences is an integrated drug development solution company offering pharmaceutical and biotechnology companies a proven, flexible approach to preclinical and clinical pharmacology studies, including formulation, manufacturing, and analytical services. For over 25 years, Altasciences has been partnering with sponsors to help support educated, faster, and more complete early drug development decisions. Altasciences’ integrated, full-service solutions include preclinical safety testing, clinical pharmacology and proof of concept, bioanalysis, program management, medical writing, biostatistics, clinical monitoring, and data management, all customizable to specific sponsor requirements. Altasciences helps sponsors get better drugs to the people who need them, faster.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20230209005658/en/
Contact information
Julie-Ann Cabana
Altasciences
+1 514 601-9763
jcabana@altasciences.com
About Business Wire
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
KnowBe4 Report Reveals Security Training Reduces Global Phishing Click Rates by 86%13.5.2025 15:00:00 EEST | Press release
KnowBe4, the world-renowned cybersecurity platform that comprehensively addresses human risk management, today launched its “Phishing by Industry Benchmarking Report 2025” which measures an organization’s Phish-prone™ Percentage (PPP) — the percentage of employees likely to fall for social engineering or phishing attacks, indicating the organization’s overall susceptibility to phishing threats. This year’s report found a global average baseline PPP of 33.1%, meaning a third of employees interact with phishing simulations before taking part in best-practice security awareness training (SAT). The data underscores the significant impact of SAT in mitigating risk. The rapid decline in the global PPP following the implementation of training — falling by 40% in just three months and by a total of 86% after 12 months — demonstrates that ongoing, effective training leads to lasting behavior change and a substantial reduction in vulnerability to cybersecurity threats. This highlights the critic
Armis Announces New Global Technology Integration Partners to Bolster Organizations’ Cyber Resilience13.5.2025 15:00:00 EEST | Press release
Armis, the cyber exposure management & security company, today announced that it has added 10 global technology integration partners over the past quarter. These integrations increase the functionality and efficiency of organizations’ existing technology stacks with added benefits from Armis’ platform and solutions. “Relying on siloed security solutions is no longer enough to gain a comprehensive, real-time understanding of an organization’s attack surface,” said Nadir Izrael, CTO and Co-Founder at Armis. “Integrating Armis’ best-in-class platform with other leading vendors’ offerings empowers businesses to consolidate their technology stacks. By driving greater value in their security investments, organizations can ensure their entire attack surface is continuously defended and managed.” New Armis global technology integration partners include AnzenOT, Brinqa, ColorTokens, EasyVista, SaltyCloud, Salvador Tech, SIGA, Spectro Cloud, Stellar Cyber, and Synqly. From compliance to network
Kyriba Unveils Agentic AI TAI to Transform Finance with Security, Compliance & Trust13.5.2025 14:35:00 EEST | Press release
Kyriba, a global leader in liquidity performance, today introduced its agentic AI solution, TAI – a significant advancement in the safe, compliant use of generative AI in finance operations to improve productivity and efficiency amid continued economic uncertainty. Powered by Kyriba's embedded Large Language Model (LLM) and over 20 years of unmatched global liquidity data, TAI simplifies complex workflows, identifies risks with predictive analytics, and enhances data-driven decision-making across treasury, payments, risk management and working capital. Poised to transform finance and treasury operations without relying on third-party LLM integrations, TAI is a key component of Kyriba’s Trusted AI portfolio. This platform-wide approach prioritizes industry-leading data privacy while empowering enterprise leaders to make faster, smarter decisions with human judgement and responsibility at the center. Kyriba’s approach directly addresses the "Trust Gap" – the growing divide between the pr
BeiGene to Present at the RBC Capital Markets Global Healthcare Conference13.5.2025 13:01:00 EEST | Press release
BeiGene, Ltd. (NASDAQ: ONC; HKEX: 06160; SSE: 688235), a global oncology company that will change its name to BeOne Medicines Ltd., today announced it will participate in the RBC Capital Markets Global Healthcare Conference on May 20, 2025, with a fireside chat at 10 a.m. EDT. The live webcast of this event can be accessed from the investors section of the Company’s website at http://ir.beigene.com/, https://hkexir.beigene.com/, https://sseir.beigene.com/. An archived replay will be available for 1 year following the event. About BeiGene BeiGene, which will change its name to BeOne Medicines, is a global oncology company that is discovering and developing innovative treatments that are more accessible and affordable to cancer patients worldwide. With a broad portfolio, we are expediting development of our diverse pipeline of novel therapeutics through our internal capabilities and collaborations. We are committed to radically improving access to medicines for far more patients who need
IQM’s First Quantum Computer in Asia-Pacific Goes Online, Set to Open Office in Seoul13.5.2025 12:09:00 EEST | Press release
IQM Quantum Computers, a global leader in superconducting quantum computers, has announced expanding its presence in Asia-Pacific with a new office opening in South Korea in June 2025, following the installation of its first quantum system at Chungbuk National University (CBNU). This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250513710683/en/ From left to right: Ben Lee and Mikko Välimäki of IQM Quantum Computers, Professor Kim Kiwoong of Chungbuk National University, Jyri Järviaho, Ambassador of Finland to South Korea, Jaana Tuomi, of Enter Espoo, Guensuk Ko of CBIST The office in Seoul reinforces IQM’s dedication to collaborating with research and academic institutions, high-performance computing (HPC) centers, and enterprises in advancing quantum technology. It also supports South Korea in building a vibrant quantum ecosystem and achieving the goals of its national quantum strategy. As part of the expansion, IQM has appoin
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom